These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9365190)

  • 1. Regulation of aromatase activity within the breast.
    Miller WR; Mullen P; Sourdaine P; Watson C; Dixon JM; Telford J
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):193-202. PubMed ID: 9365190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of aromatase activity by cytokines, PGE2 and 2-methoxyoestrone-3-O-sulphamate in fibroblasts derived from normal and malignant breast tissues.
    Purohit A; Ghilchik MW; Leese MP; Potter BV; Reed MJ
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):167-72. PubMed ID: 15862962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
    Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aromatase and breast cancer].
    Miller WR; Howie F; Mason I
    Vopr Onkol; 2001; 47(2):182-6. PubMed ID: 11383454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
    Miller WR; Stuart M; Sahmoud T; Dixon JM
    Br J Cancer; 2002 Oct; 87(9):950-5. PubMed ID: 12434282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase and the breast: regulation and clinical aspects.
    Miller WR
    Maturitas; 2006 Jul; 54(4):335-41. PubMed ID: 16730141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of breast cancer-associated aromatase promoters.
    Chen D; Reierstad S; Lu M; Lin Z; Ishikawa H; Bulun SE
    Cancer Lett; 2009 Jan; 273(1):15-27. PubMed ID: 18614276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biology of aromatase inhibitors: pharmacology/endocrinology within the breast.
    Miller WR
    Endocr Relat Cancer; 1999 Jun; 6(2):187-95. PubMed ID: 10731108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
    Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
    Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatase in the normal breast and breast cancer.
    Brodie A; Lu Q; Nakamura J
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):281-6. PubMed ID: 9365202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatase inhibitors: new endocrine treatment of breast cancer.
    Brueggemeier RW
    Semin Reprod Med; 2004 Feb; 22(1):31-43. PubMed ID: 15083379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of aromatase activity in breast tumours: the role of the immune system.
    Singh A; Purohit A; Duncan LJ; Mokbel K; Ghilchik MW; Reed MJ
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):185-92. PubMed ID: 9365189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
    Rubin GL; Zhao Y; Kalus AM; Simpson ER
    Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase inhibitors in breast cancer therapy.
    Brueggemeier RW
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):181-91. PubMed ID: 12113240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between prostaglandin E(2), liver receptor homologue-1, and aromatase in breast cancer.
    Zhou J; Suzuki T; Kovacic A; Saito R; Miki Y; Ishida T; Moriya T; Simpson ER; Sasano H; Clyne CD
    Cancer Res; 2005 Jan; 65(2):657-63. PubMed ID: 15695411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor necrosis factor alpha-stimulated aromatase activity by microtubule-stabilizing agents, paclitaxel and 2-methoxyestradiol.
    Purohit A; Singh A; Ghilchik MW; Reed MJ
    Biochem Biophys Res Commun; 1999 Jul; 261(1):214-7. PubMed ID: 10405348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oestrogen formation in breast: clinical and biological importance.
    Dowsett M; Detre S; Rowlands M; Grimshaw R
    J Endocrinol; 1996 Sep; 150 Suppl():S59-63. PubMed ID: 8943788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatase inhibitors and breast cancer.
    Miller WR
    Minerva Endocrinol; 2006 Mar; 31(1):27-46. PubMed ID: 16498362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of novel retinoic acid metabolism blocking agent (VN/14-1) on letrozole-insensitive breast cancer cells.
    Belosay A; Brodie AM; Njar VC
    Cancer Res; 2006 Dec; 66(23):11485-93. PubMed ID: 17145897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase in the context of breast and endometrial cancer. A review.
    Jongen VH; Hollema H; Van Der Zee AG; Heineman MJ
    Minerva Endocrinol; 2006 Mar; 31(1):47-60. PubMed ID: 16498363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.